Combined treatment of pancreatic cancer xenograft with (90)Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor

AIM: To investigate the therapeutic effect of combined integrin α(6)β(4)-targeted radioimmunotherapy (RIT) and PI3K/mTOR inhibitor BEZ235 in a pancreatic cancer model. METHODS: Phosphorylation of Akt, mTOR, the downstream effectors eukaryotic initiation factor 4E binding protein 1 (4EBP1) and S6 rib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Aung, Winn, Tsuji, Atsushi B, Sudo, Hitomi, Sugyo, Aya, Ukai, Yoshinori, Kouda, Katsushi, Kurosawa, Yoshikazu, Furukawa, Takako, Saga, Tsuneo, Higashi, Tatsuya
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2017
Matèries:
Basic Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698248/
https://ncbi.nlm.nih.gov/pubmed/29204055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i42.7551
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars